Therapy of recurrent colorectal cancers
Schildberg, F.W.; Lange, V.; Thies, E.; Meyer, G.
Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 56(8): 509-514
1985
ISSN/ISBN: 0009-4722 PMID: 4042768 Document Number: 253377
Colorectal cancers treated for cure by operative means show tumour recurrences and metastases in about 20% of the patients. Of these colon or rectal cancers 75 and 90% respectively can be only operated for palliation. These patients have a better prognosis than those operated primarily for palliation. 25% of the cases especially with suture line recurrences can be operated upon radically enough and exhibit a total five year survival rate of 50%.
Document emailed within 1 workday
Related Documents
Koda, K.; Glassy, M.C.; McKnight, M.E.; Yasutomi, J.; Saito, N.; Dan, M.; Nakajima, N. 2001: Immunotherapy for recurrent colorectal cancers with human monoclonal antibody SK-1 Anticancer Research 21(1b): 621-627Bettstetter, M.; Rümmele, P.; Hofstädter, F.; Dietmaier, W. 2006: A new quantitative DNA-methylation analysis of MSi colorectal cancers helps to separate sporadic colorectal cancers from HNPCC-candidates Verhandlungen der Deutschen Gesellschaft für Pathologie 90: 236-243
Suzuki, O.; Kumamoto, K.; Chika, N.; Fukuchi, M.; Kumagai, Y.; Ishibashi, K.; Mochiki, E.; Akagi, K.; Yamaguchi, K.; Ishida, H. 2014: Effect of chemotherapy on the inoperable or recurrent colorectal cancers in patients with lynch syndrome Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(12): 1770-1772
Kubota, K.; Kato, H.; Tachimori, Y.; Watanabe, H.; Yamaguchi, H.; Nakanishi, Y.; Iinuma, G. 2001: Surgical therapy for recurrent esophageal cancers at anastomoses after esophagectomy Hepato-Gastroenterology 48(41): 1364-1367
Bosslet, K.; Schwarz, A.; Steinstraesser, A.; Kuhlmann, L.; Seidel, L.; Schulz, G. 1988: Immunoscintigraphy of colorectal cancers and specific immunotherapy of pancreatic cancers using monoclonal antibodies Wiener Medizinische Wochenschrift 138(11-12): 255-257
Sakurai, Y.; Kodaira, S.; Teramoto, T.; Sugano, K.; Abe, O.; Ohtake, H.; Iri, H. 1989: Clinical evaluation of serum level of NCC-ST-439 as a new tumor marker for colorectal diseases--fluctuation of serum NCC-ST-439 in patients with colorectal cancers before and after surgery Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(9): 3205-3212
Rousseau, J.; Mathieu, G.; Fenton, J.; Cuzin, J. 1973: Radiotherapy of malpighian cancers of the anus. Telecobalt therapy of anal canal cancers Journal de Radiologie d'Electrologie et de Medecine Nucleaire 54(8-9): 622-626
Adenis, L.; Duval, G.; Demaille, M.C. 1979: Epidemiology of colorectal cancers Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 24(8): 649-652
Lièvre, A.; Mitry, E. 2003: Chemotherapy for colorectal cancers Journal de Chirurgie 140(1): 52-55
Lauterbach, M.; Dehne, A.; Hesse, V.; Höfig, G. 1987: CEA determination in the follow-up of colorectal cancers Zentralblatt für Chirurgie 112(15): 968-974
Notarnicola, M.; Caruso, M.Gabriella.; Tutino, V.; De Nunzio, V.; Gigante, I.; De Leonardis, G.; Veronese, N.; Rotolo, O.; Reddavide, R.; Stasi, E.; Miraglia, C.; Nouvenne, A.; Meschi, T.; De' Angelis, G.Luigi.; Di Mario, F.; Leandro, G. 2018: Nutrition and lipidomic profile in colorectal cancers Acta Bio-Medica: Atenei Parmensis 89(9-S): 87-96
Thiagalingam, S.; Lisitsyn, N.A.; Hamaguchi, M.; Wigler, M.H.; Willson, J.K.; Markowitz, S.D.; Leach, F.S.; Kinzler, K.W.; Vogelstein, B. 1996: Evaluation of the FHIT gene in colorectal cancers Cancer Research 56(13): 2936-2939
Zhan, J.; Liu, J-ping.; Zhu, Z-hua.; Yao, H-rui.; Chen, C-yan. 2004: Relationship between COX-2 expression and clinicopathological features of colorectal cancers Chinese Medical Journal 117(8): 1151-1154
van den Broek, M.H.; Jhanwar, S.C.; Fodde, R.; Chaganti, R.S.; Meera Khan, P.M. 1993: P53 mutations in colorectal cancers in the patients of Metropolitan New York Anticancer Research 13(5C): 1769-1772
Rohner, A. 1982: Indications for the surgical treatment of recurring colorectal cancers and their metastases Helvetica Chirurgica Acta 48(6): 873-878
Misset, J.L. 1997: Chemotherapy of advanced colorectal cancers after failure of a treatment with fluoropyrimidine La Revue du Praticien 47(12 Spec No): S29-S35
Chereches, G.; Barbos, O.; Buiga, R.; Balacescu, O.; Iancu, D.; Todor, N.; Balacescu, L.; Miron, N.; Bejinariu, N.; Ciuleanu, T.-E. 2017: Biomarkers for the early detection of relapses in metastatic colorectal cancers Journal of Buon: Official Journal of the Balkan Union of Oncology 22(3): 658-666
Geryk, E.; Horváth, T.; Konecný, M. 2011: The expected worldwide burden of oesophagus, stomach and colorectal cancers Vnitrni Lekarstvi 57(12): 1006-1011
Ljuslinder, I.; Malmer, B.; Isaksson-Mettävainio, M.; Oberg, A.; Henriksson, R.; Stenling, R.; Palmqvist, R. 2009: ErbB 1-4 expression alterations in primary colorectal cancers and their corresponding metastases Anticancer Research 29(5): 1489-1494
Klingler, K.; Zhang, X.; Menghini, T.; Metzger, U.; Largiadèr, F. 1989: Effect of blood transfusions on the survival of patients with colorectal cancers Helvetica Chirurgica Acta 55(5): 685-688